Westlake Chemical Partners (WLKP) Common Equity (2013 - 2026)

Westlake Chemical Partners' Common Equity history runs 14 years deep, the most recent figure standing at $256.1 million for Q1 2026.

• Quarterly Common Equity fell 68.11% year-over-year to $256.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $256.1 million (down 68.11% YoY) and the FY2025 annual result came in at $802.4 million, down 3.25% from the prior year.
• Common Equity was $256.1 million for Q1 2026 at Westlake Chemical Partners, down from $802.4 million in the prior quarter.
• Across five years, Common Equity topped out at $976.2 million in Q1 2022 and bottomed at $256.1 million in Q1 2026.
• A 5-year average of $798.8 million and a median of $848.2 million in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity advanced 6.91% — and 2025, when it tumbled 68.89%.
• Westlake Chemical Partners' Common Equity stood at $903.7 million in 2022, then declined by 5.25% to $856.2 million in 2023, then decreased by 3.15% to $829.3 million in 2024, then dropped by 3.25% to $802.4 million in 2025, then sank by 68.08% to $256.1 million in 2026.
• Business Quant data shows WLKP's Common Equity at $256.1 million in Q1 2026, $802.4 million in Q4 2025, and $260.6 million in Q3 2025.